Company / Operating Margin
Biogen Operating Margin History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
25.9%
FY2021
5-year range
25.9% / 25.9%
FY2017-FY2021
Trend
-23.6%
vs FY2020
Sector context
#17 of 133
Health Care
What the data says
Biogen's operating margin of 25.9% is higher than 87% of companies in the Health Care sector (FY2021). Declined from 49.0% to 25.9% over the past 2 years.
Based on SEC 10-K filings.
25.9% in FY2021 with a 5-year CAGR of -19.1%. Top quartile in the Health Care sector.
Declined from 49.0% to 25.9% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -17.9pp
- 5-Year Change
- -19.1pp
- 10-Year Change
- -
Sector benchmark
Top 13% in Health CareTop 13% of 133This company 25.9% Sector average -914.0%
▼
+102.8% above sector average
Key checks
Key Insights
- In FY2021, operating margin decreased 23.6% year-over-year.
- Currently 939.9pp above the Health Care sector average.
- Peak operating margin was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | 25.9% | -23.6% |
| FY2020 | 33.8% | -30.9% |
| FY2019 | 49.0% | +11.9% |
| FY2018 | 43.8% | +0.5% |
| FY2017 | 43.5% | -3.2% |
| FY2016 | 45.0% | -1.0% |
As of FY2021 · SEC 10-K · Updated Mar 3, 2026